EPIQ

New Philips Mini TEE ultrasound transducer helps improve cardiac care for more patients

Retrieved on: 
Wednesday, January 31, 2024
ICU, Surgeon, PHG, Workflow, Heart, Ventricular septal defect, AI, Catheter, 3D, Patient, Twilight anesthesia, Diagnosis, TEE, FDA, Columbia University, Mini, Echocardiography, Society, Physician, Risk, Cardiology, AEX, Detection, EPIQ, Medical imaging

Cardiovascular ultrasound has played a key role in the evolution of early diagnosis of structural heart disease, led by a technology pioneered by Philips: the ‘transesophageal echocardiography’ (TEE) ultrasound transducer.

Key Points: 
  • Cardiovascular ultrasound has played a key role in the evolution of early diagnosis of structural heart disease, led by a technology pioneered by Philips: the ‘transesophageal echocardiography’ (TEE) ultrasound transducer.
  • Announced today, Philips’ new X11-4t Mini 3D TEE transducer is shifting that balance and opening 3D TEE imaging to previously unaddressed patients [5].
  • “As a pioneer and leading innovator in cardiac ultrasound, our 3D ultrasound technology plays a critical role in many cardiac procedures.
  • The Philips X11-4t ultrasound transducer is scheduled for commercial availability in 2024 and is pending CE mark in Europe.

Philips improves workflow and efficiency with next generation ultrasound systems EPIQ Elite and Affiniti at #RSNA23

Retrieved on: 
Monday, November 27, 2023
Travel, Ultrasound, AEX, Transducer, Workflow, Acquisition, EPIQ, MD, Ultra, MVI, Heart, University, Obstetrics, Patient, Diagnosis, PHG, Gynaecology, RSNA, Medical imaging

Amsterdam, the Netherlands and Chicago, USA – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today placed workflow and efficiency at the heart of the next generation of its flagship ultrasound systems EPIQ Elite and Affiniti at #RSNA23 .

Key Points: 
  • Amsterdam, the Netherlands and Chicago, USA – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today placed workflow and efficiency at the heart of the next generation of its flagship ultrasound systems EPIQ Elite and Affiniti at #RSNA23 .
  • The systems feature new automated tools and a common user interface coupled with transducer compatibility across Philips ultrasound systems, including the recently introduced Compact Ultrasound 5000 Series .
  • These latest advances are demonstrating a positive impact on patient and staff satisfaction with customers worldwide by helping to improve workflow and provide greater scanning efficiency.
  • Demonstrations of Philips’ latest EPIQ Elite and Affiniti ultrasound systems, along with live scanning will be available in the Philips Booth #6730 at #RSNA23.

Philips launches new-AI enabled innovations at #RSNA23 that free up healthcare providers to focus on patient care

Retrieved on: 
Sunday, November 26, 2023
Radiology, Digital radiography, Google Images, Digital, MRI, Helium, AWS, AEX, Transducer, Hand, EPIQ, Health, Hospital, Environmental health, Informatics, Patient, Diagnosis, PHG, RSNA, Amazon Web Services, Medical imaging

With 45% of radiologists reporting symptoms of burnout, Philips’ innovations across diagnostic imaging and enterprise informatics are focused on freeing up time for clinical staff through enhanced workflows and improved efficiency.

Key Points: 
  • With 45% of radiologists reporting symptoms of burnout, Philips’ innovations across diagnostic imaging and enterprise informatics are focused on freeing up time for clinical staff through enhanced workflows and improved efficiency.
  • The company also launched its new ‘care means the world’ campaign at the event, highlighting that improving human health and environmental health go hand in hand.
  • “Philips is teaming up with healthcare providers to optimize workflows so they can spend more time focusing on patients,” said Bert van Meurs , Chief Business Leader of Precision Diagnosis and Image Guided Therapy at Philips.
  • Philips HealthSuite Imaging is a cloud-based next generation of Philips Vue PACS, enabling radiologists and clinicians to adopt new capabilities faster, increase operational efficiency and improving patient care.

EXL appoints Vishal Chhibbar as Chief Growth and Strategy Officer

Retrieved on: 
Monday, July 10, 2023
Data management, EPIQ, EXL, Marketing, CPA Australia, Pearlasia Gamboa, GE Capital, Chhibber, Xerox, Creativity, Digital technology, Knowledge, Growth, American Express, Management

NEW YORK, July 10, 2023 (GLOBE NEWSWIRE) -- EXL [NASDAQ: EXLS], a leading data analytics and digital operations and solutions company, announced the appointment of Vishal Chhibbar as executive vice president and chief growth and strategy officer.

Key Points: 
  • NEW YORK, July 10, 2023 (GLOBE NEWSWIRE) -- EXL [NASDAQ: EXLS], a leading data analytics and digital operations and solutions company, announced the appointment of Vishal Chhibbar as executive vice president and chief growth and strategy officer.
  • He will report to Rohit Kapoor, vice chairman and chief executive officer of EXL and will be an executive committee member.
  • The appointment marks Chhibbar’s return to EXL after serving as the company’s chief financial officer from 2009 to 2019, where he instituted some of EXL’s foundational growth strategies.
  • Prior to that, he was the president and chief financial officer of EPIQ, a global legal tech-enabled service leader.

Disc Presents Positive Initial Data from Phase 2 BEACON Trial of Bitopertin in Patients with Erythropoietic Protoporphyria (EPP) at European Hematology Association (EHA) 2023 Congress

Retrieved on: 
Friday, June 9, 2023
EPIQ, Sodium- and chloride-dependent glycine transporter 1, Protoporphyrin IX, European Hematology Association, Metallicity, Disc, Week, EPP, Bitopertin, Quality of life, First grade, Pain, Congress, Sunlight, IRON, Patient, Erythropoietic protoporphyria, EHA, XLP, Photosensitivity, Poster, Safety, Disease, Pharmaceutical industry, Medical device, Sewage treatment, PPIX

The initial trial data demonstrated consistent decreases in PPIX, significant increases in reported sunlight tolerance and improvements in measures of patient quality of life.

Key Points: 
  • The initial trial data demonstrated consistent decreases in PPIX, significant increases in reported sunlight tolerance and improvements in measures of patient quality of life.
  • “We’re delighted to share these initial, positive data from BEACON, which provide the first clinical evidence supporting our therapeutic hypothesis of bitopertin in EPP.
  • Due to batch processing of samples, the data cutoff for PPIX data was April 7, 2023.
  • Management will host a call to review the presented data on Friday, June 9th at 7:30 am ET.

Philips and TriHealth announce multi-year partnership at heart of new TriHealth Heart & Vascular Institute on the campus of Bethesda North Hospital

Retrieved on: 
Thursday, February 9, 2023
PHG, Education, Patient, EPIQ, Heart, TriHealth, NYSE, Health, AEX, Affinity marketing, Cardiology, Physician, Bethesda North Hospital, Nurses station, Partnership, Harold, Investment, Workflow, Health status of Asian Americans, Pharmaceutical industry, Medical imaging

As one of the top integrated health systems in greater Cincinnati, TriHealth is committed to providing access to the highest quality medical services for the communities it serves.

Key Points: 
  • As one of the top integrated health systems in greater Cincinnati, TriHealth is committed to providing access to the highest quality medical services for the communities it serves.
  • Over the last few years, TriHealth has made significant investments, including its recent affiliation with the Cleveland Clinic Heart, Vascular & Thoracic Institute, to establish itself as the region’s destination heart and vascular program.
  • Partnering with Philips is the latest in TriHealth enterprise collaborations focused on sharing best practices and developing new treatments and therapies to achieve the best possible outcomes for heart patients across the region.
  • “TriHealth understands that it takes both technology and true partnership to deliver the innovation needed to address today’s healthcare challenges,” said Jeff DiLullo, chief market leader, Philips North America.

Kaleyra Announces CEO Transition Plan and Significant Board Enhancements

Retrieved on: 
Monday, December 12, 2022
API, Software, Ottawa, Mobile, MapInfo Corporation, Communication, Telecommunication, Geography, COVID-19, Jurisprudence, Alfred University, Cooper, BPO, Treasury, Organizational behavior, Retirement, Perception, Hallam L. Movius, Partnership, Software as a service, NYSE, Growth, Organization, KLR, Russian Venture Company, EPIQ, Financial technology, PricewaterhouseCoopers, Fordham University, SHI International Corp, Alvarez and Marsal, Ohio University, Investment, Alvarez, Science, Record, TSX, Scientific Games, Sustainability Accounting Standards Board, Regulation, Coronavirus, Columbia University, Hawker Beechcraft, ASX, TCS, Finance, Management, Kaleyra, Theretra alorica, Accounting

NEW YORK, Dec. 12, 2022 /PRNewswire/ -- Kaleyra, Inc. (NYSE: KLR) (NYSE American: KLR WS) ("Kaleyra" or the "Company"), an enterprise Communication Platform as a Service (CPaaS) business, today announced a CEO transition plan and significant enhancements to its Board of Directors (the "Board") to reposition the Company for sustainable growth and value creation.

Key Points: 
  • NEW YORK, Dec. 12, 2022 /PRNewswire/ -- Kaleyra, Inc. (NYSE: KLR) (NYSE American: KLR WS) ("Kaleyra" or the "Company"), an enterprise Communication Platform as a Service (CPaaS) business, today announced a CEO transition plan and significant enhancements to its Board of Directors (the "Board") to reposition the Company for sustainable growth and value creation.
  • The Board has retained a leading independent executive search firm to assist with the CEO search process.
  • Dr. Avi Katz, Chairman of Kaleyra's Board, commented, "On behalf of the Board, I would like to thank Dario for his many years of service to the Company as CEO.
  • We look forward to a seamless transition and continuing to work with Dario as a member of the Board."

AMIH Majority Owned Subsidiary, EPIQ Scripts, Obtains Additional 27 U.S. State Board of Pharmacy Licenses Expanding its Online Mail-Order Pharmacy Operations

Retrieved on: 
Tuesday, November 29, 2022
COVID-19, Cyprus Securities and Exchange Commission, EPIQ, Master service agreement, Prescription, Insurance, Exercise, Telehealth, North Dakota State Board of Pharmacy v. Snyder's Drug Stores, Inc., Security (finance), MSA, Pharmacy, Risk, Form, OTCQB, Quality of life

Dallas, Texas, Nov. 29, 2022 (GLOBE NEWSWIRE) -- American International Holdings Corp. (OTCQB: AMIH), (“AMIH” or the “Company”), a diversified holding company that develops, acquires, and operates technology-based health and wellness companies, is pleased to announce that its majority owned subsidiary, EPIQ Scripts, LLC (“EPIQ Scripts”), has obtained an additional 27 state board of pharmacy licenses expanding its online mail-order specialty compounding pharmacy operation. Securing and obtaining licenses and accreditations in all 50 states across the U.S. has been one of EPIQ Scripts’ primary initiatives since inception in order to attract diverse telemedicine companies seeking to reach and support customers on a national level.

Key Points: 
  • More information about the MSA can be found in more detail on the Form 8-K filed by AMIH on September 8, 2022.
  • Securing pharmacy licenses in all 50 states across the U.S. has been one of our primary goals over the last several months.
  • Today the AMIH portfolio encompasses telemedicine and other virtual health platforms, subscriber based primary care and concierge medicine plans, and an online digital mail order pharmacy.
  • If we update one or more forward-looking statements, no inference should be drawn that we will make additional updates with respect to those or other forward-looking statements.

Philips launches new compact ultrasound system at RSNA 2022, allowing first-time-right diagnosis for more patients

Retrieved on: 
Monday, November 28, 2022
Philips, Obstetrics, Diagnosis, EPIQ, LV, RSNA, Innosight, Patient, Disinfectant, Radiological Society of North America, Ultrasound, Workflow, Travel, Transducer, MD, NYSE, Compact, Gynaecology, Learning curve, AEX, FDA, PHG, GLS, Medical imaging, Affinity Designer

Philips new Compact 5000 Series aims to bring the diagnostic quality associated with premium cart-based ultrasound systems to more patients.

Key Points: 
  • Philips new Compact 5000 Series aims to bring the diagnostic quality associated with premium cart-based ultrasound systems to more patients.
  • Designed for portability and versatility without compromising image quality or performance, the Compact 5000 series facilitates first-time-right ultrasound exams for more patients.
  • Philips Ultrasound Compact System 5000 Series complements Philips comprehensive portfolio of diagnostic ultrasound systems for every level of care and clinical setting, ranging from its ultra-mobile Lumify Handheld Ultrasound and hand-carried tablet InnoSight, and value-based ClearVue ultrasound systems, to its high-end and premium ultrasound Affiniti and EPIQ Elite systems.
  • Visitors to the Philips booth (#6730) at RSNA can view the new Ultrasound Compact 5000 Series in action with live scanning.

Swift Navigation Raises $100 Million Series D Financing Round to Bring Safe and Precise Navigation to Every Vehicle on the Planet

Retrieved on: 
Tuesday, October 18, 2022
Eclipse, SAN, CORS, IOT, Transport, Efficiency, Agriculture, Smartphone, Satellite navigation, Original equipment manufacturer, Twitter, New Enterprise Associates, Technology, Automation, Solution, Software, 2011–12 Coppa Italia, Alauda, GNSS, Industry, NEA, CEO, Safety, ADAS, GLOBE, Robotics, EPIQ, Continuity, Satellite navigation device, Surveying, Swift

The Series D Round was led by SK Inc. and Potentum Partners with strong support from Swifts existing investors, including New Enterprise Associates (NEA), Eclipse Ventures and EPIQ Capital Group.

Key Points: 
  • The Series D Round was led by SK Inc. and Potentum Partners with strong support from Swifts existing investors, including New Enterprise Associates (NEA), Eclipse Ventures and EPIQ Capital Group.
  • The Series D Round included new investors: FM Capital, OVN Capital, TELUS Ventures, TWM Venture Co., Buckley Ventures, Schox Venture Capital and additional independent investors.
  • Swifts technology is now powering several of the largest automotive and commercial vehicle fleets on the road today, supporting enhanced navigation and ADAS.
  • Learn more about how Swift is building a safer and more connected future at swiftnav.com .